Precedo Pharmaceuticals Co., Ltd.
Records under this name other than the patents Precedo Pharmaceuticals Co., Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 3 patents it holds.
Showing 1 to 4 of 4 · Back to Precedo Pharmaceuticals Co., Ltd.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,975,082 | Inhibitor of FLT3 kinase and use thereof Lapsed on the fee record Ended Apr 13, 2025 · From the USPTO record | Lapsed on the fee record | Ended Apr 13, 2025 | From the USPTO record |
| US 10,793,543 | Selective C-KIT kinase inhibitor Lapsed on the fee record Ended Oct 6, 2024 · From the USPTO record | Lapsed on the fee record | Ended Oct 6, 2024 | From the USPTO record |
| US 10,781,214 | Kinase inhibitor against wild-type and mutant EGFR Lapsed on the fee record Ended Sep 22, 2024 · From the USPTO record | Lapsed on the fee record | Ended Sep 22, 2024 | From the USPTO record |
| US 10,350,210 | EGFR and ALK dual inhibitor Lapsed on the fee record Ended Jul 16, 2023 · From the USPTO record | Lapsed on the fee record | Ended Jul 16, 2023 | From the USPTO record |